Enlivex Therapeutics RDO Ltd.

2 clinical trials · Sponsor

Record	Firm	Date
A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy (NCT05581719)	Enlivex Therapeutics RDO Ltd.	2022-11-15
Phase 1/2 Study Evaluating Safety and Potential Efficacy of Allocetra-OTS Via Pressurized Intra-Peritoneal Aerosol Chemotherapy as Add-on to Standard of Care Chemotherapy for Treatment of Peritoneal Metastasis (NCT05431907)	Enlivex Therapeutics RDO Ltd.	2022-06-29

Every clearance here is in the API, with alerts when new ones post.